相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Racial Inequality in Receipt of Medications for Opioid Use Disorder
Michael L. L. Barnett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2023)
Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021
Christopher M. Jones et al.
JAMA NETWORK OPEN (2023)
Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19
Elizabeth A. Samuels et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2022)
Early buprenorphine-naloxone initiation for opioid use disorder reduces opioid overdose, emergency room visits and healthcare cost compare to late initiation
Tianyu Sun et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2022)
Expanding Current Approaches to Solve the Opioid Crisis
Carlos Blanco et al.
JAMA PSYCHIATRY (2022)
Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomes
James B. Anderson et al.
SUBSTANCE ABUSE (2022)
Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019
Pia M. Mauro et al.
JAMA NETWORK OPEN (2022)
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019"
Noa Krawczyk et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2022)
African Americans now outpace whites in opioid-involved overdose deaths: a comparison of temporal trends from 1999 to 2018
Debra Furr-Holden et al.
ADDICTION (2021)
Opioid Prescribing in the 2016 Medicare Fee-for-Service Population
Matthew L. Maciejewski et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2021)
Quality of Buprenorphine Care for Insured Adults With Opioid Use Disorder
Kelly E. Anderson et al.
MEDICAL CARE (2021)
Growing racial/ethnic disparities in buprenorphine distribution in the United States, 2007-2017
Megan S. Schuler et al.
DRUG AND ALCOHOL DEPENDENCE (2021)
The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada
Micah Piske et al.
ADDICTION (2020)
Gaps In Access To Opioid Use Disorder Treatment For Medicare Beneficiaries
Samantha J. Harris et al.
HEALTH AFFAIRS (2020)
Characteristics of Office-Based Buprenorphine Prescribers for Medicare Patients
Rohit Abraham et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2020)
Validity of Race and Ethnicity Codes in Medicare Administrative Data Compared With Gold-standard Self-reported Race Collected During Routine Home Health Care Visits
Olga F. Jarrin et al.
MEDICAL CARE (2020)
Buprenorphine prescription dispensing rates and characteristics following federal changes in prescribing policy, 2017-2018: A cross-sectional study
Douglas R. Roehler et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year
George Pro et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Geographic proximity to buprenorphine treatment providers in the US
James R. Langabeer et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare Beneficiaries
Tami L. Mark et al.
JAMA NETWORK OPEN (2020)
Incidence of Treatment for Opioid Use Disorder Following Nonfatal Overdose in Commercially Insured Patients
Austin S. Kilaru et al.
JAMA NETWORK OPEN (2020)
Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States
William C. Goedel et al.
JAMA NETWORK OPEN (2020)
Socioeconomic marginalization and opioid-related overdose: A systematic review
Jenna van Draanen et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: A prognostic study
Wei-Hsuan Lo-Ciganic et al.
PLOS ONE (2020)
Examining the neighborhood-level socioeconomic characteristics associated with fatal overdose by type of drug involved and overdose setting
Keith Chichester et al.
ADDICTIVE BEHAVIORS (2020)
Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018
Daniel M. Hartung et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction
S. L. Calcaterra et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2019)
The case for a medication first approach to the treatment of opioid use disorder
Rachel P. Winograd et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2019)
Association Between the Number of Certified Buprenorphine Prescribers and the Quantity of Buprenorphine Prescriptions: Evidence from 2015 to 2017
Lee-Kai Lin et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2019)
Predictors of Medication-Assisted Treatment Initiation for Opioid Use Disorder in an Interdisciplinary Primary Care Model
Rebecca E. Cantone et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2019)
US trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018
Robin Ghertner
DRUG AND ALCOHOL DEPENDENCE (2019)
Trends In Buprenorphine Prescribing By Physician Specialty
Hefei Wen et al.
HEALTH AFFAIRS (2019)
County-level access to opioid use disorder medications in medicare Part D (2010-2015)
Amanda J. Abraham et al.
HEALTH SERVICES RESEARCH (2019)
Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder
Rebecca L. Haffajee et al.
JAMA NETWORK OPEN (2019)
Association of Disability With Mortality From Opioid Overdose Among US Medicare Adults
Yong-Fang Kuo et al.
JAMA NETWORK OPEN (2019)
Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016
M. Eugenia Socias et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees
Bradley D. Stein et al.
SUBSTANCE ABUSE (2018)
Opioid Overdose Hospitalizations among Medicare-Disability Beneficiaries
Jillian L. Peters et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2018)
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population
Jake R. Morgan et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2018)
Mortality Quadrupled Among Opioid-Driven Hospitalizations, Notably Within Lower-Income And Disabled White Populations
Zirui Song
HEALTH AFFAIRS (2017)
Trends in Opioid-related Inpatient Stays Shifted After the US Transitioned to ICD-10-CM Diagnosis Coding in 2015
Kevin C. Heslin et al.
MEDICAL CARE (2017)
Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration
Ajay Manhapra et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Use of Opioid Agonist Therapy for Medicare Patients in 2013
Anna Lembke et al.
JAMA PSYCHIATRY (2016)
Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program
Adam J. Gordon et al.
JOURNAL OF ADDICTION MEDICINE (2015)
The Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level Analysis
Hannah K. Knudsen
JOURNAL OF STUDIES ON ALCOHOL AND DRUGS (2015)
Measures of Social Deprivation That Predict Health Care Access and Need within a Rational Area of Primary Care Service Delivery
Danielle C. Butler et al.
HEALTH SERVICES RESEARCH (2013)
分享论文
